Bristol-Myers Squibb's Next 8 Months: What To Expect

By: via Benzinga
In a report published Wednesday, analysts at Morgan Stanley maintained their Overweight rating on Bristol-Myers Squibb Co (NYSE: BMY). ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.